Latest Posts › Intellectual Property Protection

Share:

Protecting Antibody Innovations: Searching for Equivalents under The Doctrine of Equivalents —A Discussion of Teva v. Eli Lilly...

United States courts have recently tightened the written description requirements for antibody claims. The scope of issued claims is now often limited to antibodies with specific sequences of the CDR and the heavy chain and...more

5 Key Takeaways | Current Perspectives Around the Convergence of Life Sciences and IT [Video]

Kilpatrick Townsend Partners Andrew Serafini and Patrick Njeim recently joined other thought leaders as featured speakers for the IP Symposium: Current Perspectives Around the Convergence of Life Sciences and IT. The event...more

5 Key Takeaways: Current Perspectives Around the Convergence of Life Sciences and IT

The Life Science Washington Institute recently celebrated World IP Day 2022 by sponsoring the “IP Symposium: Current Perspectives Around the Convergence of Life Sciences and IT.” Kilpatrick Townsend partners Andrew Serafini...more

Pushing Boundaries When Patenting Ranges

Inventions with numerical ranges are valuable across different technologies. Obtaining claims with numerical ranges provide competitive advantages to patent owners. Frequently, a claimed range in an application may need to be...more

Statement of Invention or “Hunting Expedition”?: Written Description for Claimed Ranges

“A written description . . . requires a statement of an invention, not an invitation to go on a hunting expedition to patch together after the fact a synthetic definition of an invention.” For claims reciting ranges,...more

Federal Circuit Decides Teva-Lilly Spat for Antibody Compositions and Methods

On August 16, 2021, the Federal Circuit handed down two rulings related to patents issued to Teva, which involve therapeutic antibodies targeting a calcitonin gene-related peptide (“CGRP”). In both cases, the Federal Circuit...more

Late But Not Too Late | Submitting Post-Filing Data During Patent Prosecution in Selected Jurisdictions

Intellectual Property counsel often face the dilemma of when to file a patent application: as soon as possible, or wait and gather more support? Filing an application “early” helps to avoid anticipatory prior art but if the...more

USPTO Announces COVID-19 Provisional Application Pilot Program

The United States Patent and Trademark Office (USPTO) announced a new COVID-19 Provisional Application Pilot Program (PAPP) on Wednesday, September 16, 2020. The USPTO will defer the provisional application filing fees for up...more

European Patent Office COVID-19-Related Extension Period Ends Tuesday, June 2, 2020

We previously published an alert that the European Patent Office (EPO), had issued a Notice that extended the times to file papers that could not be filed due to disruptions caused by the COVID-19 pandemic. The EPO extended...more

USPTO COVID-19 Prioritized Examination Pilot Program (PEPP) Announced

UPDATED: MAY 13, 2020: Although the USPTO Notice published on May 8, 2020, the Federal Register Notice, upon which the PEPP program is effective, will publish tomorrow, May 14, 2020 (and will be accessible here). The USPTO...more

Further Extensions for EPO Deadlines Available (Updated)

We previously published an alert that the European Patent Office (EPO), the European Union Intellectual Property Office (EUIPO) and United States Patent and Trademark Office (USPTO) had issued Notices that extended the times...more

Further Extensions for EPO Deadlines Available

We previously published an alert that the European Patent Office (EPO), the European Union Intellectual Property Office (EUIPO) and United States Patent and Trademark Office (USPTO) had issued Notices that extended the times...more

COVID -19-Related Delays in Filing Patent and Trademark Documents

The European Patent Office (EPO), the European Union Intellectual Property Office (EUIPO) and the United State Patent and Trademark Office (USPTO) have each announced some relaxation of certain rules and procedures to...more

13 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide